MARKET

JNCE

Jounce Therapeutics Inc
JNCE
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-7.2075
3.489
0.5307
98,954,679.84
Atea Pharmaceuticals Surges Over on Potential Takeover Bid
TipRanks · 05/22 19:42
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss
NASDAQ · 05/04 13:04
Jounce Acquisition: Exploring Whether It Is Worth It To Pay Up For CVR Value
Seeking Alpha · 04/18 20:26
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics
NASDAQ · 04/11 12:57
5 Stocks to Buy as the Drug Industry Rebounds in 2023
NASDAQ · 04/10 14:07
Jounce Therapeutics To End Proposed Business Combination With Redx Pharma Following Takeover Offer From Concentra Biosciences
Benzinga · 04/03 07:42
Jounce (JNCE) Up 21% on Accepting Concentra's Buyout Offer
NASDAQ · 03/28 16:26
Buyout Offer Sends Jounce Jumping 20%
TipRanks · 03/27 20:48
More

Webull offers kinds of Jounce Therapeutics Inc stock information, including NASDAQ:JNCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNCE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNCE stock methods without spending real money on the virtual paper trading platform.